Cumberland Pharmaceuticals declares special dividend of $1.50/share, authorizes $5M buyback

CUMBERLAND PHARMACEUTICALS INC

Special cash dividend of $1.50 per share, payable July 31, 2026 to holders of record July 23, 2026.
Board authorized open-market share repurchase program of up to $5 million, replacing prior $10M program.
Dividend follows $100M cash received from Apotex strategic transaction; up to $11M additional payments expected.
Several board members plan to establish new share purchase plans to increase holdings.
Company retains pipeline of ifetroban for Duchenne, systemic sclerosis, IPF, and cancer metastasis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.